GlassScriptPhysician profile
Syed Haider
NPI 1366096752
$10,847.88
in general payments reported to CMS, 2019-2025
19 companies · $2,338 in 2025
The $2,338 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $17.21 · 2023: $3,663 · 2024: $4,829 · 2025: $2,338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $7,650 · Food and Beverage: $2,359 · Travel and Lodging: $822.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $7,650.00 |
| Food and Beverage | $2,359.10 |
| Travel and Lodging | $821.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $7,673.80 | 2023-2025 | Tacticath Ablation Catheter, Sensor Enabled, Assurity, Tacticath |
| Medtronic, INC. | $1,076.86 | 2024-2025 | Micra, Linq II, Corevalve Evolut R |
| Amgen INC. | $566.24 | 2023-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $308.09 | 2024-2025 | Camzyos, Eliquis |
| Pfizer INC. | $289.56 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $245.52 | 2024-2025 | Lokelma |
| Alnylam Pharmaceuticals INC. | $216.27 | 2025 | Onpattro |
| Edwards Lifesciences Corporation | $99.14 | 2024 | Pascal |
| Lexicon Pharmaceuticals, INC. | $51.02 | 2023 | Inpefa |
| Boston Scientific Corporation | $49.75 | 2023 | Watchman Flx, Watchman |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.91 | 2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $39.62 | 2025 | |
| Janssen Pharmaceuticals, INC | $37.32 | 2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $33.47 | 2024-2025 | |
| Actelion Pharmaceuticals US, INC. | $33.29 | 2024 | Opsumit, Uptravi |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $25.59 | 2025 | Angio-Seal, Tr Band |
| Bridgebio Pharma, INC. | $21.92 | 2025 | Attruby |
| Abiomed | $21.30 | 2025 | |
| Abbvie INC. | $17.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Haider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.